PRECISION BIOSCIENCES INC (DTIL) Operating Income (Loss) USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Precision Biosciences Inc quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2024.
  • Precision Biosciences Inc Operating Income (Loss) for the quarter ending March 31, 2024 was -$4.19 M, a 68.6% increase year-over-year.
  • Precision Biosciences Inc Operating Income (Loss) for the twelve months ending March 31, 2024 was -$34.6 M, a 28.5% increase year-over-year.
  • Precision Biosciences Inc annual Operating Income (Loss) for 2023 was -$43.7 M, a 29.8% increase from 2022.
  • Precision Biosciences Inc annual Operating Income (Loss) for 2022 was -$62.3 M, a 58.2% decline from 2021.
  • Precision Biosciences Inc annual Operating Income (Loss) for 2021 was -$39.4 M, a 64.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$34.6 M -$4.19 M +$9.17 M +68.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$43.7 M -$6.03 M -$15.3 M -165% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$28.4 M -$12.4 M +$2.31 M +15.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$30.8 M -$12 M +$17.6 M +59.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-04
Q1 2023 -$48.3 M -$13.4 M +$14 M +51.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$62.3 M $9.26 M +$40 M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$102 M -$14.7 M -$3.13 M -27.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$99.2 M -$29.6 M -$51.2 M -237% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$48 M -$27.3 M -$8.59 M -45.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$39.4 M -$30.7 M -$7.24 M -30.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$32.1 M -$11.5 M +$14.5 M +55.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$46.6 M $21.6 M +$54.4 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$101 M -$18.7 M +$8.75 M +31.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$110 M -$23.5 M -$1.62 M -7.41% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$108 M -$26 M -$4.07 M -18.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$104 M -$32.8 M -$8.94 M -37.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$95.2 M -$27.5 M -$8 M -41% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$87.2 M -$21.9 M -$5.76 M -35.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 -$81.4 M -$22 M -$11.5 M -110% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$69.9 M -$23.9 M -$11.7 M -96.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$58.2 M -$19.5 M -$10.3 M -111% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$47.9 M -$16.1 M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$10.4 M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$12.1 M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$9.24 M Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.